Inc.'s stock is performing at -16.67% on the year. (TROV) to Buy with no …
Estimated Earnings
TrovaGene (TROV) stock is spiking on Monday afternoon as the company enters an agreement with FedMed for access to cancer monitoring tests and services. Trovagene (TROV) stock is climbing on heavy trading volume …
Spring
The legal version of this article can be accessed at https://baseballnewssource.com/markets/trovagene-inc-trov-downgraded-by-maxim-group/509286.html. Insiders acquired a total of 29,716 shares of company stock worth …
shares
Corporate insiders own 10.70% of the company's stock. In the last Quarter, TrovaGene, Inc. The principal of ATR is very similar to other volatility …
Maxim Group
Headquartered in San Diego, CA, TrovaGene Inc. (TROV - Free Report) , a developer of circulating ... reflecting growing traction of the Trovera and Precision Cancer Monitoring (PCM) technologies. Stock Performance The …
Reports Wider
The stock has a consensus rating of "Hold" and an average price target …
shares